Development asset linked to Hua Medicine in public FDA and regional records. Molecular target: Hexokinase-4.
- Target
- Hexokinase-4
- Mechanism
- Hexokinase type IV activator
pharma · Type II Diabetes Mellitus
Hua Medicine
Hua Medicine Limited
Hua Medicine drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Hua Medicine pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Hua Medicine drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.